First Liu et al. suggested that combination therapy involving IFN-α-2b inhalation combined with lopinavir/ritonavir and low-dose corticosteroids contributed to the observed 0% mortality in their COVID-19 patients, but without reporting any numerical data (Liu et al., 2020). The gene discussed is IFNA1; the disease is COVID-19.